Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 58 , ISSUE 2 ( April-June, 2024 ) > List of Articles

CASE REPORT

Recurrence of Fever after Antitubercular Therapy: Think of Immune Reconstitution Inflammatory Syndrome—A Case Report

Manisha Gulia, Harpreet Singh, Vikas Suri

Keywords : Antitubercular therapy, Case report, GeneXpert Mycobacterium tuberculosis, Nonsteroidal anti-inflammatory drugs, Tuberculosis-associated immune reconstitution inflammatory syndrome

Citation Information : Gulia M, Singh H, Suri V. Recurrence of Fever after Antitubercular Therapy: Think of Immune Reconstitution Inflammatory Syndrome—A Case Report. J Postgrad Med Edu Res 2024; 58 (2):74-75.

DOI: 10.5005/jp-journals-10028-1663

License: CC BY-NC 4.0

Published Online: 05-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an uncommon phenomenon in an immunocompetent host. It may present in paradoxical and unmasking forms. In any patient with clinical deterioration after an initial response to antitubercular therapy, paradoxical reaction should be kept as an important differential after ruling out resistance to therapy. Here we present a young male with mediastinal and abdominal lymph node tuberculosis having TB-IRIS after 4 weeks of initiation of antitubercular therapy.


HTML PDF Share
  1. Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2007;11:1290–1295. PMID: 18034948.
  2. Cheng VC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:803–809. DOI: 10.1007/s10096-002-0821-2
  3. Novak RM, Richardson JT, Buchacz K, et al. Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 2012;26:721–730. DOI: 10.1097/QAD.0b013e3283511e91
  4. Geri G, Passeron A, Heym B, et al. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection 2013;41:537–543. DOI: 10.1007/s15010-012-0376-9
  5. Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003;22:597–602. DOI: 10.1007/s10096-003-0998-z
  6. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:251–261. DOI: 10.1016/S1473-3099(10)70026-8
  7. Andrade BB, Singh A, Narendran G, et al. Mycobacterial antigen driven activation of CD14++CD16− monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome. PLoS Pathog 2014;10:e1004433. DOI: 10.1371/journal.ppat.1004433
  8. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010;24:2381–2390. DOI: 10.1097/QAD.0b013e32833dfc68
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.